We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. A splice acceptor variant in RGS6 associated with intellectual disability, microcephaly, and cataracts disproportionately promotes expression of a subset of RGS6 isoforms

    Intellectual disability (ID) is associated with an increased risk of develo** psychiatric disorders, suggesting a common underlying genetic factor....

    K. E. Ahlers-Dannen, J. Yang, ... R. A. Fisher in Journal of Human Genetics
    Article 09 February 2024
  2. Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases

    The last decade (2013–2023) has seen unprecedented successes in the clinical translation of therapeutic antisense oligonucleotides (ASOs). Eight such...

    Suxiang Chen, Saumya Nishanga Heendeniya, ... Rakesh N. Veedu in BioDrugs
    Article Open access 22 January 2024
  3. Meta-analysis of Osteopontin splice variants in cancer

    Background

    The cytokine Osteopontin is a mediator of tumor progression and cancer metastasis. In 2006, we reported that (in addition to the...

    Yu An, Gulimirerouzi Fnu, ... Georg F. Weber in BMC Cancer
    Article Open access 24 April 2023
  4. Estimating the proportion of nonsense variants undergoing the newly described phenomenon of manufactured splice rescue

    A recent report described a nonsense variant simultaneously creating a donor splice site, resulting in a truncated but functional protein. To explore...

    Bushra Haque, David Cheerie, ... Gregory Costain in European Journal of Human Genetics
    Article Open access 27 November 2023
  5. The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death

    There is an incomplete understanding of the burden of splice-disrupting variants in definitively associated inherited heart disease genes and whether...

    Emma S. Singer, Joshua Crowe, ... Richard D. Bagnall in npj Genomic Medicine
    Article Open access 11 October 2023
  6. Characterisation of a novel OPA1 splice variant resulting in cryptic splice site activation and mitochondrial dysfunction

    Autosomal dominant optic atrophy (DOA) is an inherited optic neuropathy that results in progressive, bilateral visual acuity loss and field defects. OPA1...

    Joshua Paul Harvey, Patrick Yu-Wai-Man, Michael Edward Cheetham in European Journal of Human Genetics
    Article Open access 09 May 2022
  7. Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells

    Objective

    Osteopontin (OPN) is a well-known glycoprotein involved in numerous pathobiological processes, including cancer. Despite having five splice...

    Mohammad Kamalabadi-Farahani, Amir Atashi, ... Seyed Sajjad Aghayan in BMC Research Notes
    Article Open access 05 September 2022
  8. Insulin receptor alternative splicing in breast and prostate cancer

    Cancer etiology represents an intricate, multifactorial orchestration where metabolically associated insulin-like growth factors (IGFs) and insulin...

    **yu Li, Gena Huang in Cancer Cell International
    Article Open access 08 February 2024
  9. Loss-of-function of activity-dependent neuroprotective protein (ADNP) by a splice-acceptor site mutation causes Helsmoortel–Van der Aa syndrome

    Mutations in ADNP result in Helsmoortel–Van der Aa syndrome. Here, we describe the first de novo intronic deletion, affecting the splice-acceptor...

    Claudio Peter D’Incal, Dale John Annear, ... R. Frank Kooy in European Journal of Human Genetics
    Article 29 February 2024
  10. The differences in drug disposition gene induction by rifampicin and rifabutin are unlikely due to different effects on important pregnane X receptor (NR1I2) splice variants

    Rifampicin and rifabutin can activate the pregnane X receptor (PXR, NR1I2 ), thereby inducing pharmacokinetically important genes/proteins and...

    Julie Nilles, Johanna Weiss, ... Dirk Theile in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 18 October 2023
  11. Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression

    Introduction

    Splice modulators have been assessed clinically in treating haematologic malignancies exhibiting splice factor mutations and acute...

    Mark Sellin, Ryan Mack, ... Jiwang Zhang in British Journal of Cancer
    Article 14 April 2022
  12. Pervasive occurrence of splice-site-creating mutations and their possible involvement in genetic disorders

    The search for causative mutations in human genetic disorders has mainly focused on mutations that disrupt coding regions or splice sites. Recently,...

    Narumi Sakaguchi, Mikita Suyama in npj Genomic Medicine
    Article Open access 18 March 2022
  13. Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer

    Background

    Alternative RNA splicing is widely dysregulated in cancers including lung adenocarcinoma, where aberrant splicing events are frequently...

    April Lo, Maria McSharry, Alice H. Berger in BMC Cancer
    Article Open access 16 December 2022
  14. Neonatal-lethal dilated cardiomyopathy due to a homozygous LMOD2 donor splice-site variant

    Dilated cardiomyopathy (DCM) is characterized by cardiac enlargement and impaired ventricular contractility leading to heart failure. A single report...

    Michaela Yuen, Lisa Worgan, ... Sandra T. Cooper in European Journal of Human Genetics
    Article Open access 26 January 2022
  15. How VEGF-A and its splice variants affect breast cancer development – clinical implications

    Background

    Altered expression levels and structural variations in the vascular endothelial growth factor (VEGF) have been found to play important...

    Hivin Al Kawas, Inas Saaid, ... Maria Margarete Karsten in Cellular Oncology
    Article Open access 18 March 2022
  16. Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites

    Background

    The association between M segment splicing and pathogenicity remains ambiguous in human influenza A viruses. In this study, we aimed to...

    Yi-Ju Han, Kuo-Ming Lee, ... Shin-Ru Shih in Journal of Biomedical Science
    Article Open access 03 February 2023
  17. Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis

    Background

    Papillomas of the breast pose challenges for treatment decisions as their risk for transformation to breast cancer is low but not...

    Piotr Ziółkowski, Marta Woźniak, ... Georg F. Weber in Breast Cancer Research
    Article Open access 29 September 2022
  18. Expression of Dystrophin Dp71 Splice Variants Is Temporally Regulated During Rodent Brain Development

    Dystrophin Dp71 is the major product of the Duchenne muscular dystrophy ( DMD ) gene in the brain, and its loss in DMD patients and mouse models leads...

    Mayram González-Reyes, Jorge Aragón, ... Cecilia Montanez in Molecular Neurobiology
    Article Open access 28 May 2024
  19. Gene expression and alternative splicing contribute to adaptive divergence of ecotypes

    Regulation of gene expression is a critical link between genotype and phenotype explaining substantial heritable variation within species. However,...

    Peter A. Innes, April M. Goebl, ... Nolan C. Kane in Heredity
    Article 09 December 2023
  20. Alternative splicing and environmental adaptation in wild house mice

    A major goal of evolutionary genetics is to understand the genetic and molecular mechanisms underlying adaptation. Previous work has established that...

    David N. Manahan, Michael W. Nachman in Heredity
    Article 27 November 2023
Did you find what you were looking for? Share feedback.